Increasing recognition of the importance of aldehyde oxidase in drug development and discovery

Drug Metabolism Reviews

Volumn 43, Issue 3, 2011, Pages 374-386

  Garattini, Enrico ^a   Terao, Mineko ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

AOX1; Cancer; Drug metabolism; Molybdenum; Obesity; Prodrugs; Xanthine oxidase

Indexed keywords

5 FLUORO 2 PYRIMIDINONE; 5 IODO 2 PYRIMIDINONE 2 DEOXYRIBOSE; ADIPONECTIN; ALDEHYDE OXIDASE; ALDEHYDE OXIDASE 1; ALDEHYDE OXIDASE 3; ALDEHYDE OXIDASE 3L1; ALDEHYDE OXIDASE 4; BETA CARBOLINE; CHLORPROMAZINE; FENOFIBRATE; HETEROCYCLIC COMPOUND; ISOENZYME; MENADIONE; MESSENGER RNA; N(1) METHYL 2 PYRIDINE 5 CARBOXAMIDE; PYRIMIDINE ANTAGONIST; RALOXIFENE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; XANTHINE OXIDASE; XENOBIOTIC AGENT; ZEBULARINE;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; DRUG DESIGN; DRUG METABOLISM; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SYNTHESIS; HUMAN; NONHUMAN; OBESITY; OXIDATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALDEHYDE OXIDASE; ANIMALS; DRUG DESIGN; DRUG DISCOVERY; HUMANS; ISOENZYMES; MOLECULAR STRUCTURE; NEOPLASMS; OXIDATION-REDUCTION; PHARMACEUTICAL PREPARATIONS; SUBSTRATE SPECIFICITY;

EID: 79960719085     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602532.2011.560606     Document Type: Article

References (134)

1. Alfaro, J. F. , Joswig-Jones, C. A., Ouyang, W., Nichols, J., Crouch, G. J., Jones, J. P. (2009). Purifcation and mechanism of human aldehyde oxidase expressed in Escherichia coli. Drug Metab Dispos 37:2393-2398.
2. Andersson, A., Ritz, C., Lindgren, D., Eden, P., Lassen, C., Heldrup, J., et al. (2007). Microarray-based classifcation of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 21:1198-1203. (Pubitemid 46831808)
3. Badwey, J. A., Robinson, J. M., Karnovsky, M. J., Karnovsky, M. L. (1981). Superoxide production by an unusual aldehyde oxidase in guinea pig granulocytes. Characterization and cytochemical localization. J Biol Chem 256:3479-3486. (Pubitemid 11082515)
4. Barbier, G. G., Joshi, R. C., Campbell, E. R., Campbell, W. H. (2004). Purifcation and biochemical characterization of simplifed eukaryotic nitrate reductase expressed in Pichia pastoris. Protein Expr Purif 37:61-71. (Pubitemid 39027244)
5. Beedham, C (1987). Molybdenum hydroxylases: biological distribution and substrate-inhibitor specifcity. Prog Med Chem 24:85-127.
6. Beedham, C. (1997). Te role of non-P450 enzymes in drug oxidation. Pharm World Sci 19:255-263. (Pubitemid 27511692)
7. Beer, D. G., Kardia, S. L., Huang, C. C., Giordano, T. J., Levin, A. M., Misek, D. E., et al. (2002). Gene-expression profles predict survival of patients with lung adenocarcinoma. Nat Med 8:816-824.
8. Beroukhim, R., Brunet, J. P., Di Napoli, A., Mertz, K. D., Seeley, A., Pires, M. M., et al. (2009). Patterns of gene expression and copy-number alterations in von-Hippel Lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 69:4674-4681.
9. Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., et al. (2007). Assessing the signifcance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 104:20007-20012.
10. Blaveri, E., Simko, J. P., Korkola, J. E., Brewer, J. L., Baehner, F., Mehta, K., et al. (2005). Bladder cancer outcome and subtype classifcation by gene expression. Clin Cancer Res 11:4044-4055. (Pubitemid 40791568)
11. Bredel, M., Bredel, C., Juric, D., Harsh, G. R., Vogel, H., Recht, L. D., et al. (2005). High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res 65:4088-4096. (Pubitemid 40775645)
12. Buchholz, M., Braun, M., Heidenblut, A., Kestler, H. A., Kloppel, G., Schmiegel, W., et al. (2005). Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 24:6626-6636. (Pubitemid 41486793)
13. Cates, L. A., Jones, G. S., Jr., Good, D. J., Tsai, H. Y., Li, V. S., Caron, N., et al. (1980). Cyclophosphamide potentiation and aldehyde oxidase inhibition by phosphorylated aldehydes and acetals. J Med Chem 23:300-304. (Pubitemid 10129974)
14. Chang, C. N., Doong, S. L., Cheng, Y. C. (1992). Conversion of 5-iodo-2-pyrimidinone-2'-deoxyribose to 5-iodo-deoxyuridine by aldehyde oxidase. Implication in hepatotropic drug design. Biochem Pharmacol 43:2269-2273.
15. Chen, X., Leung, S. Y., Yuen, S. T., Chu, K. M., Ji, J., Li, R., et al. (2003). Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 14:3208-3215. (Pubitemid 37013121)
16. Cheung, K. J., Tzameli, I., Pissios, P., Rovira, I., Gavrilova, O., Ohtsubo, T., et al. (2007). Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab 5:115-128. (Pubitemid 46187493)
17. Choi, Y. L., Tsukasaki, K., O'Neill, M. C., Yamada, Y., Onimaru, Y., Matsumoto, K., et al. (2007). A genomic analysis of adult T-cell leukemia. Oncogene 26:1245-1255.
18. Crnogorac-Jurcevic, T., Gangeswaran, R., Bhakta, V. , Capurso, G., Lattimore, S., Akada, M., et al. (2005). Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 129:1454-1463. (Pubitemid 41597388)
19. Das, P. K., Guha, S. R. (1985). In vitro pigment formation from tryptamine. Role of indole-3-acetaldehyde. Biochem Pharmacol 34:2663-2667. (Pubitemid 15041749)
20. Demontis, S., Kurosaki, M., Saccone, S., Motta, S., Garattini, E., Terao, M. (1999). Te mouse aldehyde oxidase gene: molecular cloning, chromosomal mapping, and functional characterization of the 5'-fanking region. Biochim Biophys Acta 1489:207-222.
21. Detwiller, K. Y., Fernando, N. T., Segal, N. H., Ryeom, S. W., D'Amore, P. A., Yoon, S. S. (2005). Analysis of hypoxia-related gene expression in sarcomas and efect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res 65:5881-5889. (Pubitemid 40911194)
22. Dyrskjot, L., Kruhofer, M., Tykjaer, T., Marcussen, N., Jensen, J. L., Moller, K., et al. (2004). Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classifcation. Cancer Res 64:4040-4048. (Pubitemid 38697320)
23. Eger, B. T., Okamoto, K., Enroth, C., Sato, M., Nishino, T., Pai, E. F. (2000). Purifcation, crystallization, and preliminary X-ray difraction studies of xanthine dehydrogenase and xanthine oxidase isolated from bovine milk. Acta Crystallogr D Biol Crystallogr 56:1656-1658. (Pubitemid 32040029)
24. Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Pai, E. F. (2000). Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci USA 97:10723-10728.
25. Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., et al. (2008). Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14:518-527. (Pubitemid 351655218)
26. Fischer, K., Barbier, G. G., Hecht, H. J., Mendel, R. R., Campbell, W. H., Schwarz, G. (2005). Structural basis of eukaryotic nitrate reduction: crystal structures of the nitrate reductase active site. Plant Cell 17:1167-1179. (Pubitemid 43142134)
27. Garattini, E., Fratelli, M., Terao, M. (2008). Mammalian aldehyde oxidases: genetics, evolution, and biochemistry. Cell Mol Life Sci 65:1019-1048.
28. Garattini, E., Fratelli, M., Terao, M. (2009). Te mammalian aldehyde oxidase gene family. Hum Genomics 4:119-130.
29. Garattini, E., Mendel, R., Romao, M. J., Wright, R., Terao, M. (2003). Mammalian molybdo-favoenzymes, an expanding family of proteins: structure, genetics, regulation, function, and pathophysiology. Biochem J 372:15-32. (Pubitemid 36609603)
30. Gok, F. , Ichida, K., Topaloglu, R. (2003). Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria. Nephrol Dial Transpl 18:2278-2283. (Pubitemid 37336814)
31. Graessler, J., Fischer, S. (2007). Te dual substrate specifcity of aldehyde oxidase 1 for retinal and acetaldehyde and its role in ABCA1 mediated efux. Horm Metab Res 39:775-776. (Pubitemid 350206896)
32. Gumz, M. L., Zou, H., Kreinest, P. A., Childs, A. C., Belmonte, L. S., LeGrand, S. N., et al. (2007). Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 13:4740-4749. (Pubitemid 47294780)
33. Guo, X., Lerner-Tung, M., Chen, H. X., Chang, C. N., Zhu, J. L., Chang, C. P., et al. (1995). 5-fuoro-2-pyrimidinone, a liver aldehyde oxidase-activated prodrug of 5-fuorouracil. Biochem Pharmacol 49:1111-1116.
34. Guo, Y., Lu, P., Farrell, E., Zhang, X., Weller, P., Monshouwer, M., et al. (2007). In silico and in vitro pharmacogenetic analysis in mice. Proc Natl Acad Sci USA 104:17735-17740. (Pubitemid 350210904)
35. Hall, W. W., Krenitsky, T. A. (1986). Aldehyde oxidase from rabbit liver: specifcity toward purines and their analogs. Arch Biochem Biophys 251:36-46. (Pubitemid 17192981)
36. Hao, Y., Triadaflopoulos, G., Sahbaie, P., Young, H. S., Omary, M. B., Lowe, A. W. (2006). Gene expression profling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 131:925-933. (Pubitemid 44307058)
37. Hendrix, N. D., Wu, R., Kuick, R., Schwartz, D. R., Fearon, E. R., Cho, K. R. (2006). Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res 66:1354-1362. (Pubitemid 43259914)
38. Hesberg, C., Hansch, R., Mendel, R. R., Bittner, F. (2004). Tandem orientation of duplicated xanthine dehydrogenase genes from Arabidopsis thaliana: diferential gene expression and enzyme activities. J Biol Chem 279:13547-13554. (Pubitemid 38468880)
39. Hille, R., Nishino, T. (1995). Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J 9:995-1003.
40. Hodnett, C. N., McCormack, J. J., Sabean, J. A. (1976). Oxidation of selected pteridine derivatives by mamalian liver xanthine oxidase and aldehyde oxidase. J Pharm Sci 65:1150-1154.
41. Hoshino, K., Itoh, K., Masubuchi, A., Adachi, M., Asakawa, T., Watanabe, N., et al. (2007). Cloning, expression, and characterization of male cynomolgus monkey liver aldehyde oxidase. Biol Pharm Bull 30:1191-1198. (Pubitemid 47037635)
42. Hsiao, L. L., Dangond, F., Yoshida, T., Hong, R., Jensen, R. V. , Misra, J., et al. (2001). A compendium of gene expression in normal human tissues. Physiol Genomics 7:97-104.
43. Hu, R., Xu, C., Shen, G., Jain, M. R., Khor, T. O., Gopalkrishnan, A., et al. (2006). Identifcation of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray. Life Sci 79:1944-1955. (Pubitemid 44485118)
44. Huang, D. Y., Furukawa, A., Ichikawa, Y. (1999). Molecular cloning of retinal oxidase/aldehyde oxidase cDNAs from rabbit and mouse livers and functional expression of recombinant mouse retinal oxidase cDNA in Escherichia coli. Arch Biochem Biophys 364:264-272. (Pubitemid 29394280)
45. Iacobuzio-Donahue, C. A., Maitra, A., Olsen, M., Lowe, A. W., van Heek, N. T., Rosty, C., et al. (2003). Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 162:1151-1162. (Pubitemid 36350660)
46. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., Chaudhuri, G. (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269.
47. Ishikawa, M., Yoshida, K., Yamashita, Y., Ota, J., Takada, S., Kisanuki, H., et al. (2005). Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profles of pancreatic ductal cells. Cancer Sci 96:387-393. (Pubitemid 41179739)
48. Johns, D. G. (1967). Human liver aldehyde oxidase: diferential inhibition of oxidation of charged and uncharged substrates. J Clin Invest 46:1492-1505.
49. Johns, D. G., Farquhar, D., Wolpert, M. K., Chabner, B. A., Loo, T. L. (1973). Dialkyl esters of methotrexate and 3′,5′- dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase. Drug Metab Dispos 1:580-589.
50. Kaiser, S., Park, Y. K., Franklin, J. L., Halberg, R. B., Yu, M., Jessen, W. J., et al. (2007). Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 8:R131.
51. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., et al. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563. (Pubitemid 47525152)
52. Khor, T. O., Huang, M. T., Kwon, K. H., Chan, J. Y., Reddy, B. S., Kong, A. N. (2006). Nrf2-defcient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 66:11580-11584. (Pubitemid 46094166)
53. Ki, D. H., Jeung, H. C., Park, C. H., Kang, S. H., Lee, G. Y., Lee, W. S., et al. (2007). Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 121:2005-2012.
54. Kinsella, T. J., Kunugi, K. A., Vielhuber, K. A., McCulloch, W., Liu, S. H., Cheng, Y. C. (1994). An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116. Cancer Res 54:2695-2700.
55. Kinsella, T. J., Kunugi, K. A., Vielhuber, K. A., Potter, D. M., Fitzsimmons, M. E., Collins, J. M. (1998). Preclinical evaluation of 5-iodo-2-pyrimidinone-2′-deoxyribose as a prodrug for 5-iodo-2′- deoxyuridine-mediated radiosensitization in mouse and human tissues. Clin Cancer Res 4:99-109. (Pubitemid 28062883)
56. Kinsella, T. J., Schupp, J. E., Davis, T. W., Berry, S. E., Hwang, H. S., Warren, K., et al (2000). Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2′;-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: implications for phase I study design. Clin Cancer Res 6:3670-3679.
57. Kitamura, S., Nitta, K., Tayama, Y., Tanoue, C., Sugihara, K., Inoue, T., et al. (2008). Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver. Drug Metab Dispos 36:1202-1205. (Pubitemid 351929332)
58. Kitamura, S., Sugihara, K., Nakatani, K., Ohta, S., Ohhara, T., Ninomiya, S., et al. (1999). Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans. IUBMB Life 48:607-611. (Pubitemid 30043806)
59. Kundu, T. K., Hille, R., Velayutham, M., Zweier, J. L. (2007). Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues. Arch Biochem Biophys 460:113-121. (Pubitemid 46505003)
60. Kurosaki, M., Demontis, S., Barzago, M. M., Garattini, E., Terao, M. (1999). Molecular cloning of the cDNA coding for mouse aldehyde oxidase: tissue distribution and regulation in vivo by testosterone. Biochem J 341(Pt 1):71-80. (Pubitemid 29359049)
61. Kurosaki, M., Terao, M., Barzago, M. M., Bastone, A., Bernardinello, D., Salmona, M., et al. (2004). Te aldehyde oxidase gene cluster in mice and rats. Aldehyde oxidase homologue 3, a novel member of the molybdo-favoenzyme family with selective expression in the olfactory mucosa. J Biol Chem 279:50482-50498. (Pubitemid 39577867)
62. Landi, M. T., Dracheva, T., Rotunno, M., Figueroa, J. D., Liu, H., Dasgupta, A., et al. (2008). Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One 3:e1651.
63. Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., et al. (2004). Gene expression profling identifes clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 101:811-816. (Pubitemid 38121040)
64. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403. (Pubitemid 43668737)
65. Lenburg, M. E., Liou, L. S., Gerry, N. P., Frampton, G. M., Cohen, H. T., Christman, M. F. (2003). Previously unidentifed changes in renal cell carcinoma gene expression identifed by parametric analysis of microarray data. BMC Cancer 3:31.
66. Li, H., Cui, H., Kundu, T. K., Alzawahra, W., Zweier, J. L. (2008). Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase. J Biol Chem 283:17855-17863.
67. Li, H., Kundu, T. K., Zweier, J. L. (2009). Characterization of the magnitude and mechanism of aldehyde oxidase-mediated nitric oxide production from nitrite. J Biol Chem 284:33850-33858.
68. Liu, P., Ramachandran, S., Ali Seyed, M., Scharer, C. D., Laycock, N., Dalton, W. B., et al (2006). Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res 66:4011-4019.
69. Logsdon, C. D., Simeone, D. M., Binkley, C., Arumugam, T., Greenson, J. K., Giordano, T. J., et al. (2003). Molecular profling of pancreatic adenocarcinoma and chronic pancreatitis identifes multiple genes diferentially regulated in pancreatic cancer. Cancer Res 63:2649-2657. (Pubitemid 36605209)
70. Luo, J. H., Yu, Y. P., Cieply, K., Lin, F., Defavia, P., Dhir, R., et al. (2002). Gene expression analysis of prostate cancers. Mol Carcinog 33:25-35. (Pubitemid 34052304)
71. Magee, J. A., Araki, T., Patil, S., Ehrig, T., True, L., Humphrey, P. A., et al. (2001). Expression profling reveals hepsin overexpression in prostate cancer. Cancer Res 61:5692-5696. (Pubitemid 32769078)
72. Mendel, R. R., Bittner, F. (2006). Cell biology of molybdenum. Biochim Biophys Acta 1763:621-635. (Pubitemid 44189541)
73. Mertens, J. A., Shiraishi, N., Campbell, W. H. (2000). Recombinant expression of molybdenum reductase fragments of plant nitrate reductase at high levels in Pichia pastoris. Plant Physiol 123:743-756. (Pubitemid 30411159)
74. Mira, L., Maia, L., Barreira, L., Manso, C. F. (1995). Evidence for free radical generation due to NADH oxidation by aldehyde oxidase during ethanol metabolism. Arch Biochem Biophys 318:53-58.
75. Moncada, S., Palmer, R. M., Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
76. Neumeier, M., Weigert, J., Schafer, A., Weiss, T. S., Schmidl, C., Buttner, R., et al. (2006). Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofbric acid in hepatocytes in vitro. Biochem Biophys Res Commun 350:731-735. (Pubitemid 44547907)
77. Nishimura, M., Naito, S. (2006). Tissue-specifc mRNA expression profles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab Pharmacokinet 21:357-374.
78. Nishino, T. (1994). Te conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J Biochem 116:1-6. (Pubitemid 24230774)
79. Nishino, T., Amaya, Y., Kawamoto, S., Kashima, Y., Okamoto, K. (2002). Purifcation and characterization of multiple forms of rat liver xanthine oxidoreductase expressed in baculovirus-insect cell system. J Biochem 132:597-606. (Pubitemid 35238914)
80. Nishino, T., Okamoto, K., Eger, B. T., Pai, E. F. (2008). Mammalian xanthine oxidoreductase-mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J 275:3278-3289. (Pubitemid 351813552)
81. Notterman, D. A., Alon, U., Sierk, A. J., Levine, A. J. (2001). Transcriptional gene expression profles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61:3124-3130. (Pubitemid 32691964)
82. Obach, R. S. (2004). Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab Dispos 32:89-97. (Pubitemid 38112540)
83. Obach, R. S., Huynh, P., Allen, M. C., Beedham, C. (2004). Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol 44:7-19. (Pubitemid 38005089)
84. Ohkubo, M., Sakiyama, S., Fujimura, S. (1983). Increase of nicotinamide methyltransferase and N1-methyl-nicotinamide oxidase activities in the livers of the rats administered alkylating agents. Cancer Lett 21:175-181. (Pubitemid 14217348)
85. Okamoto, K., Matsumoto, K., Hille, R., Eger, B. T., Pai, E. F., Nishino, T. (2004). Te crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition. Proc Natl Acad Sci USA 101:7931-7936. (Pubitemid 38698031)
86. Palmer, R. M., Ferrige, A. G., Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526. (Pubitemid 17085822)
87. Panchal, H. D., Vranizan, K., Lee, C. Y., Ho, J., Ngai, J., Timiras, P. S. (2008). Early anti-oxidative and anti-proliferative curcumin efects on neuroglioma cells suggest therapeutic targets. Neurochem Res 33:1701-1710.
88. Pilarsky, C., Wenzig, M., Specht, T., Saeger, H. D., Grutzmann, R (2004). Identifcation and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6:744-750. (Pubitemid 40041492)
89. Pyeon, D., Newton, M. A., Lambert, P. F., den Boon, J. A., Sengupta, S., Marsit, C. J., et al. (2007). Fundamental diferences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 67:4605-4619. (Pubitemid 46910165)
90. Reiss, J., Bonin, M., Schwegler, H., Sass, J. O., Garattini, E., Wagner, S., et al. (2005). Te pathogenesis of molybdenum cofactor defciency, its delay by maternal clearance, and its expression pattern in microarray analysis. Mol Genet Metab 85:12-20. (Pubitemid 40603020)
91. Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., et al. (2006). X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9:121-132. (Pubitemid 43202662)
92. Rivera, S. P., Choi, H. H., Chapman, B., Whitekus, M. J., Terao, M., Garattini, E., et al. (2005). Identifcation of aldehyde oxidase 1 and aldehyde oxidase homologue 1 as dioxin-inducible genes. Toxicology 207:401-409. (Pubitemid 40138937)
93. Rodriguez-Trelles, F. , Tarrio, R., Ayala, F. J. (2003). Convergent neofunctionalization by positive Darwinian selection after ancient recurrent duplications of the xanthine dehydrogenase gene. Proc Natl Acad Sci USA 100:13413-13417. (Pubitemid 37444756)
94. Rooseboom, M., Commandeur, J. N., Vermeulen, N. P. (2004). Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol Rev 56:53-102. (Pubitemid 38314580)
95. Rosenwald, A., Alizadeh, A. A., Widhopf, G., Simon, R., Davis, R. E., Yu, X., et al. (2001). Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194:1639-1647. (Pubitemid 33126814)
96. Rosowsky, A., Wright, J. E., Holden, S. A., Waxman, D. J. (1990). Infuence of lipophilicity and carboxyl group content on the rate of hydroxylation of methotrexate derivatives by aldehyde oxidase. Biochem Pharmacol 40:851-857. (Pubitemid 20246595)
97. Roth, R. B., Hevezi, P., Lee, J., Willhite, D., Lechner, S. M., Foster, A. C., et al. (2006). Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 7:67-80.
98. Sahi, J., Khan, K. K., Black, C. B. (2008). Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey, and human. Drug Metab Lett 2:176-183.
99. Saif, M. W., Berk, G., Cheng, Y. C., Kinsella, T. J. (2007). IPdR: a novel oral radiosensitizer. Exp Opin Investig Drugs 16:1415-1424. (Pubitemid 47491411)
100. Sanchez-Carbayo, M., Socci, N. D., Lozano, J., Saint, F. , Cordon-Cardo, C. (2006). Defning molecular profles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24:778-789. (Pubitemid 46622045)
101. Schumann, S., Terao, M., Garattini, E., Saggu, M., Lendzian, F., Hildebrandt, P., et al. (2009). Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1. PLoS One 4:e5348.
102. Segara, D., Biankin, A. V., Kench, J. G., Langusch, C. C., Dawson, A. C., Skalicky, D. A., et al. (2005). Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res 11:3587-3596. (Pubitemid 40627916)
103. Shyamsundar, R., Kim, Y. H., Higgins, J. P. , Montgomery, K., Jorden, M., Sethuraman, A., et al. (2005). A DNA microarray survey of gene expression in normal human tissues. Genome Biol 6:R22.
104. Sigruener, A., Buechler, C., Orso, E., Hartmann, A., Wild, P. J., Terracciano, L., et al. (2007). Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes. Horm Metab Res 39:781-789. (Pubitemid 350206898)
105. Stegmaier, K., Ross, K. N., Colavito, S. A., O'Malley, S., Stockwell, B. R., Golub, T. R. (2004). Gene expression-based high-throughput screening(GE-HTS) and application to leukemia diferentiation. Nat Genet 36: 257-263. (Pubitemid 38282750)
106. Steinberg, K. K., Relling, M. V., Gallagher, M. L., Greene, C. N., Rubin, C. S., French, D., et al. (2007). Genetic studies of a cluster of acute lymphoblastic leukemia cases in Churchill County, Nevada. Environ Health Perspect 115:158-164. (Pubitemid 46050299)
107. Su, L. J., Chang, C. W., Wu, Y. C., Chen, K. C., Lin, C. J., Liang, S. C., et al (2007). Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics 8:140.
108. Sugihara, K., Tayama, Y., Shimomiya, K., Yoshimoto, D., Ohta, S., Kitamura, S. (2006). Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridones, and intraspecies variation of the enzyme activity in rats. Drug Metab Dispos 34:208-212. (Pubitemid 43145022)
109. Talantov, D., Mazumder, A., Yu, J. X., Briggs, T., Jiang, Y., Backus, J., et al. (2005). Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 11:7234-7242. (Pubitemid 41507680)
110. Terao, M., Kurosaki, M., Barzago, M. M., Fratelli, M., Bagnati, R., Bastone, A., et al. (2009). Role of the molybdofavoenzyme aldehyde oxidase homolog 2 in the biosynthesis of retinoic acid: generation and characterization of a knockout mouse. Mol Cell Biol 29:357-377.
111. Terao, M., Kurosaki, M., Barzago, M. M., Varasano, E., Boldetti, A., Bastone, A., et al. (2006). Avian and canine aldehyde oxidases. Novel insights into the biology and evolution of molybdo-favoenzymes. J Biol Chem 281:19748-19761. (Pubitemid 44035477)
112. Terao, M., Kurosaki, M., Demontis, S., Zanotta, S., Garattini, E. (1998). Isolation and characterization of the human aldehyde oxidase gene: conservation of intron/exon boundaries with the xanthine oxidoreductase gene indicates a common origin. Biochem J 332(Pt 2):383-393. (Pubitemid 28271870)
113. Terao, M., Kurosaki, M., Marini, M., Vanoni, M. A., Saltini, G., Bonetto, V., et al. (2001). Purifcation of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes. Identifcation of a novel molybdo-favoprotein gene cluster on mouse chromosome 1. J Biol Chem 276:46347-46363.
114. Terao, M., Kurosaki, M., Saltini, G., Demontis, S., Marini, M., Salmona, M., et al. (2000). Cloning of the cDNAs coding for two novel molybdo-favoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase. J Biol Chem 275:30690-30700.
115. Valk, P. J., Verhaak, R. G., Beijen, M. A., Erpelinck, C. A., Barjesteh van Waalwijk van Doorn-Khosrovani, S., Boer, J. M., et al. (2004). Prognostically useful gene-expression profles in acute myeloid leukemia. NEJM 350:1617-1628. (Pubitemid 38528701)
116. Vanaja, D. K., Cheville, J. C., Iturria, S. J., Young, C. Y. (2003). Transcriptional silencing of zinc fnger protein 185 identifed by expression profling is associated with prostate cancer progression. Cancer Res 63:3877-3882. (Pubitemid 36917897)
117. Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., et al. (2005). Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8:393-406. (Pubitemid 41579834)
118. Ventura, S. M., Dachtler, S. L. (1980). Development and maturation of aldehyde oxidase levels in fetal hepatic tissue of C57BL/6J mice. Enzyme 25:213-219. (Pubitemid 11252524)
119. Ventura, S. M., Dachtler, S. L. (1981). Efects of sex hormones on hepatic aldehyde oxidase activity in C57BL/6J mice. Horm Res 14:250-259. (Pubitemid 11029209)
120. Vila, R., Kurosaki, M., Barzago, M. M., Kolek, M., Bastone, A., Colombo, L., et al. (2004). Regulation and biochemistry of mouse molybdo-favoenzymes. Te DBA/2 mouse is selectively defcient in the expression of aldehyde oxidase homologues 1 and 2 and represents a unique source for the purifcation and characterization of aldehyde oxidase. J Biol Chem 279:8668-8683. (Pubitemid 38295922)
121. Wachi, S., Yoneda, K., Wu, R. (2005). Interactome-transcriptome analysis reveals the high centrality of genes diferentially expressed in lung cancer tissues. Bioinformatics 21:4205-4208. (Pubitemid 41724298)
122. Wallace, T. A., Prueitt, R. L., Yi, M., Howe, T. M., Gillespie, J. W., Yfantis, H. G., et al. (2008). Tumor immunobiological diferences in prostate cancer between African-American and European-American men. Cancer Res 68:927-936. (Pubitemid 351206772)
123. Wang, P. , Zweier, J. L. (1996). Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 271:29223-29230. (Pubitemid 26382634)
124. Weigert, J., Neumeier, M., Bauer, S., Mages, W., Schnitzbauer, A. A., Obed, A., et al. (2008). Small-interference RNA-mediated knockdown of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release. FEBS Lett 582:2965-2972.
125. Welsh, J. B., Zarrinkar, P. P., Sapinoso, L. M., Kern, S. G., Behling, C. A., Monk, B. J., et al. (2001). Analysis of gene expression profles in normal and neoplastic ovarian tissue samples identifes candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 98:1176-1181. (Pubitemid 32121206)
126. Wootton, J. C., Nicolson, R. E., Cock, J. M., Walters, D. E., Burke, J. F., Doyle, W. A., et al. (1991). Enzymes depending on the pterin molybdenum cofactor: sequence families, spectroscopic properties of molybdenum, and possible cofactor-binding domains. Biochim Biophys Acta 1057:157-185.
127. Wright, J. E., Rosowsky, A., Waxman, D. J., Trites, D., Cucchi, C. A., Flatow, J., et al. (1987). Metabolism of methotrexate and gamma-tert-butyl methotrexate by human leukemic cells in culture and by hepatic aldehyde oxidase in vitro. Biochem Pharmacol 36:2209-2214. (Pubitemid 17101736)
128. Wright, R. M., McManaman, J. L., Repine, J. E. (1999). Alcohol-induced breast cancer: a proposed mechanism. Free Radic Biol Med 26:348-354. (Pubitemid 29013466)
129. Wright, R. M., Riley, M. G., Weigel, L. K., Ginger, L. A., Costantino, D. A., McManaman, J. L. (2000). Activation of the human aldehyde oxidase (hAOX1) promoter by tandem cooperative Sp1/Sp3 binding sites: identifcation of complex architecture in the hAOX upstream DNA that includes a proximal promoter, distal activation sites, and a silencer element. DNA Cell Biol 19:459-474. (Pubitemid 32186441)
130. Wurmbach, E., Chen, Y. B., Khitrov, G., Zhang, W., Roayaie, S., Schwartz, M., et al. (2007). Genome-wide molecular profles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45:938-947. (Pubitemid 46646500)
131. Yoo, C. B., Chuang, J. C., Byun, H. M., Egger, G., Yang, A. S., Dubeau, L., et al. (2008). Long-term epigenetic therapy with oral zebularine has minimal side efects and prevents intestinal tumors in mice. Cancer Prev Res (Phila Pa) 1:233-240.
132. Yusenko, M. V., Kuiper, R. P., Boethe, T., Ljungberg, B., van Kessel, A. G., Kovacs, G. (2009). High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 9:152.
133. Zannolli, R., Micheli, V. , Mazzei, M. A., Sacco, P., Piomboni, P., Bruni, E., et al. (2003). Hereditary xanthinuria type II associated with mental delay, autism, cortical renal cysts, nephrocalcinosis, osteopenia, and hair and teeth defects. J Med Genet 40:e121.
134. Zhang, X., Liu, H. H., Weller, P., Zheng, M., Tao, W., Wang, J., et al. (2011). In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor. Pharmacogenomics J 11:15-24.